BUSI, CORRADO
BUSI, CORRADO
DIP. DI PATOLOGIA SPERIMENTALE
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade.
2006 Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Busi C.; Chieco P.; Kratz F.; Manaresi F.; Pariali M.
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin
2007 Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A.
Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
2005 FIUME L.; BOLONDI L.; BUSI C.; CHIECO P.; KRATZ F.; LANZA M.; MATTIOLI A.; DI STEFANO G.
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
2008 Di Stefano G.; Fiume L.; Baglioni M.; Busi C.; Bolondi L.; Farina C.; Mori F.; Chieco P.; Pariali M.; Kratz F.; Molin L.; Salmaso S.; Caliceti P.
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis.
2006 Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; Bernardi M.
Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas.
2006 Di Stefano G.; Busi C.; Chieco P.; Pariali M.; Fiume L.
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow.
2009 Fiume L.; Baglioni M.; Busi C.; Manerba M.; Di Stefano G.